Lawrence A. Kenyon
2020
In 2020, Lawrence A. Kenyon earned a total compensation of $1.2M as Director, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Corporate Secretary at Outlook Therapeutics, a 36% decrease compared to previous year.
Compensation breakdown
| Bonus | $116,875 |
|---|---|
| Option Awards | $621,449 |
| Salary | $425,000 |
| Other | $21,010 |
| Total | $1,184,334 |
Kenyon received $621.4K in option awards, accounting for 52% of the total pay in 2020.
Kenyon also received $116.9K in bonus, $425K in salary and $21K in other compensation.
Rankings
In 2020, Lawrence A. Kenyon's compensation ranked 7,890th out of 13,090 executives tracked by ExecPay. In other words, Kenyon earned more than 39.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,890 out of 13,090 | 40th |
Division Manufacturing | 3,346 out of 5,621 | 41st |
Major group Chemicals And Allied Products | 1,355 out of 2,254 | 40th |
Industry group Drugs | 1,177 out of 1,954 | 40th |
Industry Biological Products, Except Diagnostic Substances | 277 out of 411 | 33rd |
Source: SEC filing on February 22, 2021.
Kenyon's colleagues
We found two more compensation records of executives who worked with Lawrence A. Kenyon at Outlook Therapeutics in 2020.